SecBot SecBot

ASTH

Astrana Health, Inc.
Nasdaq· Services-Management Consulting Services· Inc. DE· CIK 0001083446 Services
$37.45 −0.56 (−1.47%)
Oct 23 4:00 PM ET · prev $38.01
Market cap
$1.9B
Small cap
Consensus
Buy
88% Buy or better · 17 analysts
Median target
$53.00
+42% · range $41.00–65.00
Next earnings
Nov 5
in 10 days
1 year
+13.3%
from $33.05 · Oct 27
30 days
+6.6%
from $35.13
52-week range
$18.16–49.81
−25% from high · low Feb 12
Avg volume 20D
312.4K
shares / day
Short interest
🔒 Subscribers only
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
7
analyzed by SecBot
SecBot read MIXED 3 reports · 90 days
Balance 1 bearish · 1 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/3 ·Next Earnings date, Nov 5, 2026
Strongest BULLISH Astrana Health filed an updated investor presentation via an 8-K (Items 7.01, 9.01) that reaffirms and…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsBULLISH

    Q2 2026: 27 added (0 new), 11 trimmed or exited.

  • AnalystsBULLISH

    15 of 17 rate it Buy or better. Every target is above the price.

  • TrendUPTREND

    0% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BANK OF AMERICA CORP /DE/ADD852,145$39.5M
FMR LLCADD685,922$31.8M
WELLS FARGO & COMPANY/MNDOUBLED664,940$30.9M
MORGAN STANLEYADD433,508$20.1M
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLCTRIM249,410$11.6M
LPL Financial LLCTRIM221,696$10.3M
UBS Group AGTRIM191,956$8.9M
MILLENNIUM MANAGEMENT LLCDOUBLED190,503$8.8M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

17 analysts
Buy 88% rate it Buy or better
Strong Buy7Buy8Hold2Sell0Strong Sell0
12-month targets · 9 analysts

Price is below the lowest target. Median implies +42%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Oct 1, 2026Freedom Capital Markets
MAINTAIN
MAINTAINBuy
Sep 15, 2026Oppenheimer
INITIATE
INITIATEOutperform
Aug 11, 2026Truist Securities
MAINTAIN
MAINTAINBuy
Aug 7, 2026Barclays
MAINTAIN
MAINTAINOverweight
Jul 14, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Jul 14, 2026BTIG
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Oct 10, 2026
Vong John
SVP - Accounting (PAO)
TAX W/H$20.9K
Oct 6, 2026
Lam Thomas S.
Director
TAX W/H$97.1K
Oct 6, 2026
Sim Brandon
CEO and President
TAX W/H$365.9K
Oct 2, 2026
Basho Chandan
COO and CFO
TAX W/H$75.1K
Sep 15, 2026
Vong John
SVP - Accounting (PAO)
TAX W/H$3.7K
Sep 5, 2026
Basho Chandan
COO and CFO
TAX W/H$68.9K
Sep 5, 2026
Sim Brandon
CEO and President
TAX W/H$275.6K
Aug 31, 2026
Kitayama Mitchell W
Director
TO ISSUER$315.3K

Earnings setup

Estimates
Nov 5
reports in 10 days

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 10, 2026 Insider
Vong John surrendered for taxes 556 shares
SVP - Accounting (PAO) @ $37.55 ($20.9K)
Oct 6, 2026 Insider
Lam Thomas S. surrendered for taxes 2,624 shares
Director @ $37.00 ($97.1K)
Oct 6, 2026 Insider
Sim Brandon surrendered for taxes 9,889 shares
CEO and President @ $37.00 ($365.9K)
Sep 24, 2026 Other
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investor
Sep 23, 2026 SEC
Astrana Health filed an updated corporate investor presentation (September 2026) under Item 7.01 Regulation FD. The…
8-K — Impact 4/10
Sep 23, 2026 SEC
Astrana Health disclosed a material cybersecurity incident involving social engineering attacks that led to…
8-K — Impact 5/10
Sep 15, 2026 SEC
Astrana Health filed an updated investor presentation via an 8-K (Items 7.01, 9.01) that reaffirms and raises FY2026…
8-K — Impact 6/10
Jun 30, 2026 Inst.
BANK OF AMERICA CORP — ADD
852,145 shares ($39.5M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 5, 2026
Earnings date
ASTH Q3 2026 Earnings Scheduled — 2026-11-05
Recent
Sep 24, 2026
Press release
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. ("Astrana" or the…
Aug 6, 2026
Earnings date
ASTH Q2 2026 Earnings Scheduled — 2026-08-06
Jul 14, 2026
Earnings
Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call
ALHAMBRA, Calif., July 14, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the…
May 7, 2026
Earnings date
ASTH Q1 2026 Earnings Scheduled — 2026-05-07
Mar 3, 2026
Short interest
FTD: ASTH — 151,929 shares ($4.0M) failed to deliver
Settlement: 20260303, Price: $26.32, FTD Value: $3,998,771.28, ASTRANA HEALTH INC. COMMON STO

SecBot reports

7 filings · 1 bullish · 1 bearish · 5 neutral
All ASTH filing & press-release reports (7)